Results 231 to 240 of about 75,178 (272)
Some of the next articles are maybe not open access.
Solid Lipid Nanoparticles (SLN™)
2013Solid lipid nanoparticles (SLN™) are a new generation of drug delivery systems being exploited for several drugs since the nineties. These particles can be composed of different types of solid lipids, such as glycerides, waxes, and fatty acids, and stabilized by a wide range of surfactants.
Eliana B. Souto +2 more
openaire +1 more source
International Journal of Gynecological Cancer, 2020
To establish the bilateral pelvic concordance rate of the sentinel lymph node (SLN) and determine the likelihood of lymph node metastasis in cases of mapping failure.A database analysis was performed on 414 patients with clinical stage I endometrial cancer who underwent SLN mapping followed by robotic hysterectomy and completion pelvic (n=414, 100 ...
Amanda J Stephens +8 more
openaire +2 more sources
To establish the bilateral pelvic concordance rate of the sentinel lymph node (SLN) and determine the likelihood of lymph node metastasis in cases of mapping failure.A database analysis was performed on 414 patients with clinical stage I endometrial cancer who underwent SLN mapping followed by robotic hysterectomy and completion pelvic (n=414, 100 ...
Amanda J Stephens +8 more
openaire +2 more sources
Integrate Fuzzy Logic into SLN
2011 Seventh International Conference on Semantics, Knowledge and Grids, 2011SLN is a loosely coupled semantic data model assigned for the network resource management. Integrating fuzzy logic into SLN can be used to handle the ambiguity, uncertainty and imprecision. This paper proposes a novel data model of fuzzy semantic link network, and provides membership functions used to define the fuzzy semantic association degree ...
Ke Ren +3 more
openaire +1 more source
Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer—do we need both?
The American Journal of Surgery, 2010The aim of this study to analyze whether ultrastaging of initially negative nonsentinel lymph nodes (non-SLNs) would increase nodal positivity in colon cancer and rectal cancer.After SLN mapping (SLNM), SLNs were ultrastaged by 4 hematoxylin and eosin and 1 immunohistochemistry sections. A blinded pathologist reexamined initially negative non-SLNs by 3
David, Wiese +10 more
openaire +2 more sources
Solid lipid non-particles (SLN) [Kati lipit nanopartiküller (SLN)]
2019Colloidal drug delivery systems are one of the subjects investigated intensively in the pharmaceutical field, in recent years. Those systems include microspheres, polymeric nanoparticles, liposomes and fat emulsions. An ideal colloidal system has to carry the active ingredient contained to the site of action and must be able to release it an ...
Demirel, Müzeyyen, Yazan, Yasemin
openaire +1 more source
Lipid-Based Nanoparticles: SLN, NLC, and MAD
2019Lipid-based nanosystems have been widely proposed as novel drug carrier systems since they have gained interest as matrixes able to dissolve and to control the delivery of active molecules, on one hand improving their solubility in water and their bioavailability and on the other reducing side-effects.
R. Cortesi +3 more
openaire +2 more sources
2010
One might ask whether the work of producing representations of Weyl groups by geometric means, carried out in the previous chapter, was worth-while. Our point is that absolutely the same machinery can be applied to construct representations of sln(C) and perhaps other semisimple Lie algebras, cf. [Na2]. Many of the objects we use for studying the sln(C)
Neil Chriss, Victor Ginzburg
openaire +1 more source
One might ask whether the work of producing representations of Weyl groups by geometric means, carried out in the previous chapter, was worth-while. Our point is that absolutely the same machinery can be applied to construct representations of sln(C) and perhaps other semisimple Lie algebras, cf. [Na2]. Many of the objects we use for studying the sln(C)
Neil Chriss, Victor Ginzburg
openaire +1 more source
Sorafenib loaded SLN magnetically targeting hepatoma
2018Sorafenib, a multikinase inhibitor, has been clinically approved as the sole biological agent able to significantly improve survival in patients with advanced hepatocellular carcinoma (HCC), which are not candidates for surgical or ablative therapy. Although its effectiveness has been proven, the therapeutic response and application for local treatment
Nicoletta Depalo +14 more
openaire +2 more sources